secwatch / observer
8-K filed June 8, 2023, 7:59 PM ET ticker OGN CIK 0001821825
other confidence high sentiment neutral materiality 0.15

Organon shareholders elect all Class II directors, approve say-on-pay, ratify auditor

Organon & Co.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Organon & Co. shareholders approved To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers at the 2023-06-06 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-06-06
Exact text from the filing
For Against Abstain Broker Non-Votes 1 170,522,652 11,916,370 815,895 32,293,398
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Organon & Co. shareholders approved To ratify the appointment by the Company’s Audit Committee of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm at the 2023-06-06 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-06
Exact text from the filing
For Against Abstain Broker Non- Votes 1 215,254,031 840,020 454,264 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Organon & Co. shareholders approved To elect the four Class II directors nominated by the Company’s Board of Directors to serve until the 2025 annual meeting at the 2023-06-06 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-06
Exact text from the filing
Nominee For Withhold Abstain Broker Non- Votes 1 Carrie S. Cox 161,582,913 21,364,441 307,563 33,293,398 Alan Ezekowitz, M.D. 181,298,050 1,681,234 275,633 33,293,398 Helene Gayle, M.D. 180,024,350 2,950,230 280,337 33,293,398 Deborah Leone 181,439,869 1,544,341 270,707 33,293,398
View on SEC.gov

Browse all shareholder votes →

Organon & Co. filing history →

Source: SEC EDGAR
accession 0001104659-23-069458
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.